At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 100 enrolled
Drug / intervention
Belladonna and opioid suppository +1 moredrug
Likely dose
Belladonna and opioid suppository 16.2mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
CRAMPS Trial: Controlled Randomized Trial Assessing Maternal Post-partum Pain With Suppositories
In Brief
A Phase 4 clinical trial evaluating Belladonna and opioid suppository and Glycerin Suppository for Pain. Completed, enrolled 100 participants across 2 sites.
Detailed Summary
This trial will evaluate whether the routine use of belladonna/opium (B\&O) suppositories improve patients' self-reported pain control in the first 24-hours after delivery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2009
First PostedJan 2011
Primary CompletionSep 2011
TodayJul 2026
First PostedJan 7, 2011
Enrollment StartJul 22, 2009
Primary CompletionSep 29, 2011
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 15.5 years ago
Interventions
Belladonna and opioid suppositorydrug
Belladonna and opioid suppository 16.2mg/30mg per rectum every 8 hours for 24 hours following delivery
Glycerin Suppositorydrug
A vegetable oil suppository (placebo) per rectum every 8 hours for the first 24 hours following delivery.